HPV infection found to increase risk of lung cancer
the ONA take:
According to a new study published in the Journal of Clinical Virology, researchers have found that there is a strong association between lung tissue with human papillomavirus (HPV) infection, particularly HPV subtypes 16 and 18, and lung cancer. For the meta-analysis, the researchers searched various databases through March 2014 and identified nine studies that it total included 1,094 lung cancer cases and 484 non-cancer cases.
Statistical analyses showed that HPV infection was associated with lung cancer (Odds Ratio [OR] = 5.67, 95% CI: 3.09-10.40, P <0.001). Researchers also found that HPV subtypes 16 and 18 were similarly associated with lung cancer (OR = 6.02, 95% CI: 3.22-11.28, P <0.001). Furthermore, HPV 16 and 18 were strongly associated with lung squamous cell carcinoma (SCC) (OR = 9.78, 95% CI: 6.28-15.22, P <0.001), which was three times greater than with lung adenocarcinoma (OR = 3.69, 95% CI: 0.99-13.71, P = 0.052).
The findings suggest that HPV subtypes 16 and 18 infection significantly elevates the risk for developing SCC, indicating that there may be causal pathogenesis association between HPV and lung cancer.
Researchers have found that there is a strong association between lung tissue with HPV.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|